XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Net product sales $ 126,669 $ 94,503 $ 237,072 $ 180,773
Cost of goods sold 11,261 9,114 24,828 16,056
Gross profit 115,408 85,389 212,244 164,717
Operating expenses:        
Research and development 24,683 35,149 53,012 76,648
Selling, general, and administrative 73,576 65,423 161,605 139,380
Changes in fair value of contingent consideration payable 0 337 0 588
Restructuring charges 0 0 6,045 0
Loss on impairment of assets 0 1,134 0 1,134
Depreciation and amortization 2,182 2,206 4,336 3,463
Total operating expenses 100,441 104,249 224,998 221,213
Income (loss) from operations 14,967 (18,860) (12,754) (56,496)
Other expense:        
Interest income 1,370 1,737 2,910 3,936
Interest expense (12,512) (12,492) (24,948) (24,336)
Other expense (3,717) (10,902) (8,683) (16,840)
Income (loss) before income tax 108 (40,517) (43,475) (93,736)
Income tax expense (15,805) (2,715) (20,641) (2,428)
Net loss attributable to common stockholders $ (15,697) $ (43,232) $ (64,116) $ (96,164)
Net loss attributable to common stockholders per common share - basic (in dollars per share) $ (0.05) $ (0.15) $ (0.21) $ (0.33)
Net loss attributable to common stockholders per common share — diluted (in dollars per share) $ (0.05) $ (0.15) $ (0.21) $ (0.33)
Weighted average common shares outstanding - basic (in shares) 303,773,922 292,797,002 303,336,787 292,071,201
Weighted average common shares outstanding - diluted (in shares) 303,773,922 292,797,002 303,336,787 292,071,201